Treatment of Uncomplicated Cystitis
For premenopausal, nonpregnant women with uncomplicated cystitis, use nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days as first-line therapy. 1, 2
Defining Uncomplicated vs. Complicated Cystitis
Uncomplicated cystitis is limited to premenopausal, nonpregnant women without urological abnormalities or comorbidities, with no fever, flank pain, or signs of pyelonephritis. 2 These patients can be treated with short-course antibiotics (3-5 days). 2
Complicated cystitis includes all other patients—men, postmenopausal women, pregnant women, and those with anatomical abnormalities, immunosuppression, or diabetes—and requires longer treatment durations (7-14 days). 2 This is a critical distinction that fundamentally changes management.
Special Note on Diabetes
Women with diabetes presenting with acute cystitis but without voiding abnormalities should be treated similarly to women without diabetes. 3 The presence of diabetes alone does not automatically make cystitis "complicated" if there are no other complicating factors. 3
First-Line Treatment for Uncomplicated Cystitis (Premenopausal Women)
Primary Recommendation
- Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is the preferred first-line agent due to minimal resistance, limited collateral damage, and clinical cure rates of 88-93%. 1, 2, 4
Alternative First-Line Options
Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days is appropriate ONLY when local resistance rates are known to be <20% OR the infecting strain is confirmed susceptible. 1, 2 This 20% threshold is critical because clinical cure rates drop dramatically with resistant strains (41-54% vs 84-88% for susceptible strains). 1
Fosfomycin trometamol 3 g single dose is an appropriate alternative with minimal resistance, though it has slightly inferior microbiological cure rates (78% vs 86% for nitrofurantoin). 1, 2
Second-Line Options (Reserve for When First-Line Cannot Be Used)
Fluoroquinolones (ciprofloxacin, levofloxacin) for 3 days are highly effective but should be reserved as alternative agents due to collateral damage and the need to preserve them for more serious infections. 1, 2
β-Lactam agents (amoxicillin-clavulanate, cefdinir, cefpodoxime-proxetil) for 3-7 days have inferior efficacy and more adverse effects compared to first-line options. 1
Agents to Avoid
- Amoxicillin or ampicillin should NOT be used for empirical treatment due to poor efficacy and high worldwide resistance rates. 1
Treatment for Complicated Cystitis
Men with Cystitis
Men require fundamentally different treatment than women and should NOT receive short-course regimens. 5
Ciprofloxacin 500 mg twice daily for 7 days OR levofloxacin 500-750 mg once daily for 7 days is the preferred empiric choice due to excellent prostatic penetration. 2, 5
Nitrofurantoin 5-day courses, fosfomycin single-dose, and pivmecillinam short courses are all inadequate for male cystitis. 5
Alternative options include trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7-14 days (only if local resistance <20%) or β-lactams with good urinary penetration for 7-14 days. 5
Women with Diabetes (Without Voiding Abnormalities)
Treat the same as uncomplicated cystitis in premenopausal women: nitrofurantoin 100 mg twice daily for 5 days. 3
If voiding abnormalities are present, treat as complicated cystitis with 7-14 day regimens. 2
Other Complicated Populations
- Treatment duration should be 7-14 days rather than 3-5 days. 2
- Obtain urine culture with susceptibility testing before initiating therapy. 2
Recurrent UTI Management
Diagnostic Approach
Obtain urinalysis, urine culture, and sensitivity with each symptomatic acute cystitis episode prior to initiating treatment in patients with recurrent UTIs. 6
Patient-initiated treatment (self-start) may be offered to select recurrent UTI patients while awaiting culture results. 6
Treatment Principles
Use first-line therapy (nitrofurantoin, trimethoprim-sulfamethoxazole, fosfomycin) dependent on the local antibiogram. 6
Treat acute cystitis episodes with as short a duration of antibiotics as reasonable, generally no longer than seven days. 6
For cultures resistant to oral antibiotics, culture-directed parenteral antibiotics may be used for as short a course as reasonable, generally no longer than seven days. 6
Asymptomatic Bacteriuria
Do NOT perform surveillance urine testing in asymptomatic patients with recurrent UTIs. 6
Do NOT treat asymptomatic bacteriuria except in pregnant women and patients scheduled for invasive urinary tract procedures. 6 Women with diabetes and long-term care facility residents do not benefit from treatment of asymptomatic bacteriuria. 6
Monitoring and Follow-Up
Symptoms should improve within 48-72 hours of appropriate therapy. 2, 5
If symptoms persist or worsen, obtain urine culture and consider retreatment with a 7-day regimen using another agent. 2
For women whose symptoms do not resolve by end of treatment or recur within 2 weeks, obtain urine culture and susceptibility testing. 2
Routine post-treatment urinalysis or cultures are NOT indicated for asymptomatic patients. 2
Common Pitfalls to Avoid
Do not use fluoroquinolones as first-line therapy despite their high efficacy—this promotes resistance to agents needed for more serious infections. 1
Do not prescribe trimethoprim-sulfamethoxazole empirically if local resistance rates are ≥20% or unknown. 1, 2
Do not treat men with short-course regimens (3-5 days) designed for uncomplicated cystitis in women. 5
Do not prescribe treatment durations longer than recommended—a common problem in practice where 73-82% of prescriptions exceed guideline-recommended durations. 7
Do not treat asymptomatic bacteriuria in non-pregnant patients or those not undergoing urinary procedures. 6